Dr. Reuben Shaw discusses the collaborative relationship his lab has developed with scientists at Cell Signaling Technology. This collaboration has led to the development and validation of substrate motif antibodies that has enabled profiling of the signaling activities in metabolic diseases and cancers in Dr. Shaw’s lab and around the world.
